Gene patents face Supreme Court reckoning

Supreme Court of the United States

Medical-testing companies differ on the potential impact of the Supreme Court ruling on the Myriad Genetics BRCA1 patent. Many companies offer a range of tests. Figuring out who owns the rights to all those genes isn’t easy.

View the original article here: Gene Patents Face Reckoning

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.